Thu, 03/20/2025 - 18:32 |
Dana-Farber/Boston Childrens Cancer and Blood Disorders Center receives grant for Breakthrough Research Initiatives in the fight against Childhood Cancer |
Dana Farber |
Fri, 02/21/2025 - 17:28 |
Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements |
Dana Farber |
Mon, 01/13/2025 - 18:51 |
Dana-Farber and Gustave Roussy announce 2025 Transatlantic Exchange scientific program to focus on Radioligand Therapy |
Dana Farber |
Wed, 08/14/2024 - 16:25 |
New Study Unveils the Power of Physical Forces in Enhancing T Cell Immune Response |
Dana Farber |
Tue, 07/16/2024 - 04:15 |
U.S. News & World Report names Dana-Farber Brigham Cancer Center among nation's best for 2024-2025 |
Dana Farber |
Thu, 07/11/2024 - 19:10 |
Jose Cancelas named director of the Connell and O'Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute |
Dana Farber |
Fri, 06/07/2024 - 11:30 |
Dana-Farber hosts surprise party celebrating local teen's high school graduation |
Dana Farber |
Fri, 05/31/2024 - 20:15 |
Chandrajit P. Raut named Surgeon-in-Chief for Dana-Farber Cancer Institute |
Dana Farber |
Sun, 03/03/2024 - 08:45 |
Simone Ledward-Boseman visits Dana-Farber during Colorectal Cancer Awareness Month |
Dana Farber |
Mon, 02/04/2019 - 01:53 |
Cape Cod Hospital to join Dana-Farber Cancer Care Collaborative |
Dana Farber |
Thu, 01/24/2019 - 10:22 |
Geoffrey Shapiro receives cancer drug development award from the International Congress on Targeted Anticancer Therapies |
Dana Farber |
Wed, 01/23/2019 - 23:12 |
Long-term marijuana smoking linked to increased pulmonary disease in HIV-positive men |
Dana Farber |
Wed, 01/23/2019 - 14:58 |
Cancer Research UK tackles global cancer challenges with 60 million in funding |
Cancer Research UK |
Tue, 01/22/2019 - 00:13 |
Dana-Farber Cancer Institute researchers win Grand Challenge funding from Cancer Research UK |
Dana Farber |
Wed, 01/16/2019 - 09:40 |
Friends of Cancer Research Announces New Members to Board of Directors |
Friends of Canc... |
Thu, 01/10/2019 - 21:57 |
Remote Participation Enables Patients with ALK-Positive Lung Cancer from Across the Country to Participate in New Study of Treatment Resistance |
GO2 Foundation ... |
Mon, 01/07/2019 - 07:53 |
Personalized vaccine to be tested for the first time in patients with kidney cancer |
Dana Farber |
Fri, 01/04/2019 - 16:11 |
Researchers Awarded $1 Million to Study Optimal Use of Radioactive Drugs for Prostate Cancer Therapy |
New York Presby... |
Fri, 01/04/2019 - 07:16 |
Turning the immunological "heat" on "cold" tumors, checking checkpoint therapy resistance, yeast genomes yield virulence insights, and more. |
Broad Institute |
Wed, 01/02/2019 - 20:14 |
More than 115 Dana-Farber-affiliated physicians recognized as Top Doctors |
Dana Farber |
Wed, 12/19/2018 - 17:58 |
Neoantigen vaccine spurs immune response in glioblastoma |
Dana Farber |
Tue, 12/18/2018 - 18:34 |
Prostate cancer scoring method may underestimate mortality risk in black men |
Dana Farber |
Tue, 12/18/2018 - 10:42 |
James Terwilliger named as Executive Vice President and Chief Operating Officer at Dana-Farber Cancer Institute |
Dana Farber |
Sun, 12/16/2018 - 22:46 |
Celgene Corporation Announces Celgene Cancer Care Links Program Grant Recipients |
BMS |
Fri, 12/14/2018 - 06:10 |
Mapping cancer resistance workarounds, probing promoters in autism, profiling microbes' metabolism in IBD, and more. |
Broad Institute |